A framework for selection of blood-based biomarkers for geroscience-guided clinical trials: report from the TAME Biomarkers Workgroup

Recent advances indicate that biological aging is a potentially modifiable driver of late-life function and chronic disease and have led to the development of geroscience-guided therapeutic trials such as TAME (Targeting Aging with MEtformin). TAME is a proposed randomized clinical trial using metfo...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :GeroScience
Главные авторы: Justice, Jamie N., Ferrucci, Luigi, Newman, Anne B., Aroda, Vanita R., Bahnson, Judy L., Divers, Jasmin, Espeland, Mark A., Marcovina, Santica, Pollak, Michael N., Kritchevsky, Stephen B., Barzilai, Nir, Kuchel, George A.
Формат: Artigo
Язык:Inglês
Опубликовано: Springer International Publishing 2018
Предметы:
Review Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC6294728/
https://ncbi.nlm.nih.gov/pubmed/30151729
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11357-018-0042-y
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы